bortezomib,lenalidomide,busulfan,dexamethasone
Takeda
#ims2022 | highlights the reported median pfs of 75.3 months with a frontline regimen that is now all available in its generic versions #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma